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journal homepage: http: / /www.kjms-onl ine.comLETTER TO THE EDITORStrong CA19-9 expression associated with
multiple metastases in a case of apocrine
carcinomaTo the Editor,
Apocrine carcinoma is a rare malignancy of sweat glands
with only 38 cases being documented since 1985 [1]. This
tumor has a high potential for destructive infiltration
locally, and distant metastasis caused by spreading
through lymphatic and vascular systems to bone, lung,
and skin [2]. Here, we report an apocrine carcinoma
with elevated serum carbohydrate antigen (CA)19-9
level.
A 34-year-old woman found a soft, elastic, and
movable nodule around 0.8 cm in diameter over her left
temporal scalp area, and underwent excisional biopsy.
The pathological features showed diffuse infiltration
of pleomorphic neoplastic cells with eosinophilic cyto-
plasm, oval vesicular nuclei, and typical decapitation
sections in the apical snouts arranged in a glandular
pattern (Fig. 1A). Metastatic apocrine carcinoma was
diagnosed.
Chest computed tomography (CT) scan showed multiple
pulmonary nodules in both lung fields; the greatest being
3.8 cm in diameter (Fig. 1G). [18F] fluorodeoxyglucose
positron emission tomographyeCT showed multiple pul-
monary and bone metastases (Fig. 1H).
All laboratory investigation showed within normal
ranges, except for a high serum level of CA19-9 (9542 U/
mL). The pathology of CT-guided biopsy from the largest
lung nodule was identical with that of the scalp lesion
(Fig. 1B). Immunohistochemical staining on the scalp and
lung specimens showed strong positive staining of CA19-9
(Fig. 1D and E).
After two courses of combination chemotherapy with
cyclophosphamide, doxorubicin and etoposide (CAE), she
responded poorly, with persistent elevation of CA19-9
(11,845 U/mL). A progressively enlarged nodule over theConflicts of interest: All authors declare no conflicts of interest.
http://dx.doi.org/10.1016/j.kjms.2014.04.004
1607-551X/Copyright ª 2014, Kaohsiung Medical University. Published bright breast was found. The pathology of breast core biopsy
showed apocrine carcinoma with strongly positive CA19-9
expression (Fig. 1C and F). She was transferred due to
personal reasons.
The diagnosis of apocrine carcinoma is based on char-
acteristic pathological features of an adenocarcinoma with
decapitation secretion. Currently, there is no definite
tumor marker for this rare malignancy. CA19-9 is a tumor
marker for adenocarcinoma of the colon, stomach, and
pancreas. The elevated sialylated Lewis oligosaccharide
structure of CA19-9, presenting on the surface of tumor
cells, may be responsible for the selective homing of human
cancer cells to the endothelium by ligands for E-selectin in
the metastatic cascade [3]. The expression level of CA19-9
is implicated in the malignant behavior and a prognostic
factor for recurrence and length of survival [4].
In our case, the cancer cells from the breast, lung, and
scalp all expressed CA19-9 strongly. This implies that the
sialylated Lewis antigen is associated with neoplastic pro-
gression. A connection between the antigen on cancer cells
and the E-selectin on endothelial cells induced by inflam-
matory stimuli such as tumor necrosis factor-a or inter-
leukin-1a or b may explain the high risk of metastasis [5].
Our case provides a potential explanation of the mechanism
of metastasis.
In conclusion, we report a rare case of apocrine
carcinoma with a high serum level and strong expression
of CA19-9 in the cancer cells, which may represent a
poor prognostic factor with more aggressive tumor
growth.
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